A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

IsraelActive Not RecruitingPHASE3

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037, Arcadia, California, United States

  • Sensa Health- Site Number : 8400038, Los Angeles, California, United States

  • Newport Native MD- Site Number : 8400031, Newport Beach, California, United States

  • Sacramento Ear Nose & Throat - Roseville- Site Number : 8400064, Roseville, California, United States

  • Breathe Clear Institute of Sinus and Allergy Relief- Site Number : 8400040, Torrance, California, United States

  • Orso Health - Torrance - Hawthorne Boulevard- Site Number : 8400035, Torrance, California, United States

  • Advanced Research Associates (ARA) Professionals- Site Number : 8400011, Miami, Florida, United States

  • Paradisus Med Research - Miami- Site Number : 8400009, Miami, Florida, United States

  • Orlando ENT Associates - Orlando- Site Number : 8400008, Orlando, Florida, United States

  • Emory University School of Medicine- Grady Campus- Site Number : 8400047, Atlanta, Georgia, United States

  • Treasure Valley Medical Research- Site Number : 8400063, Boise, Idaho, United States

  • University of Chicago Medical Center- Site Number : 8400018, Chicago, Illinois, United States

  • Deaconess Clinic Allergy East- Site Number : 8400056, Evansville, Indiana, United States

  • SSM Health Saint Louis University Hospital- Site Number : 8400005, St Louis, Missouri, United States

  • Northwell Health Physician Partners Rheumatology at Great Neck- Site Number : 8400028, Great Neck, New York, United States

  • Essential Medical Research- Site Number : 8400066, Tulsa, Oklahoma, United States

  • TEN20 Clinical Research - Dallas- Site Number : 8400015, Dallas, Texas, United States

  • Houston Methodist Hospital- Site Number : 8400054, Houston, Texas, United States

  • ENT Associates of Texas - McKinne- Site Number : 8400062, McKinney, Texas, United States

  • Alamo ENT Associates- Site Number : 8400065, San Antonio, Texas, United States

  • Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400046, Norfolk, Virginia, United States

  • Investigational Site Number : 0320002, La Plata, Buenos Aires, Argentina

  • Investigational Site Number : 0320004, Rosario, Santa Fe Province, Argentina

  • Investigational Site Number : 0320001, Buenos Aires, Argentina

  • Investigational Site Number : 0320005, Buenos Aires, Argentina

  • Investigational Site Number : 0320003, Mendoza, Argentina

  • Investigational Site Number : 0400005, Graz, Austria

  • Investigational Site Number : 0400002, Linz, Austria

  • Investigational Site Number : 0400001, Vienna, Austria

  • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760002, Ribeirão Preto, São Paulo, Brazil

  • Centro Internacional de Pesquisa Clínica (CIPES)- Site Number : 0760005, São José dos Campos, São Paulo, Brazil

  • Hospital Israelita Albert Einstein- Site Number : 0760001, São Paulo, Brazil

  • Investigational Site Number : 1240005, London, Ontario, Canada

  • Investigational Site Number : 1240002, Montreal, Quebec, Canada

  • Investigational Site Number : 1240001, Québec, Quebec, Canada

  • Investigational Site Number : 1520006, Valdivia, Los Ríos Region, Chile

  • Investigational Site Number : 1520003, Talca, Maule Region, Chile

  • Investigational Site Number : 1520004, Lo Barnechea, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520002, Santiago, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520001, Santiago, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520005, Viña del Mar, Valparaiso, Chile

  • Investigational Site Number : 2460004, Helsinki, Finland

  • Investigational Site Number : 2460003, Helsinki, Finland

  • Investigational Site Number : 2460002, Kuopio, Finland

  • Investigational Site Number : 2760004, Berlin, Germany

  • Investigational Site Number : 2760007, Frankfurt, Germany

  • Investigational Site Number : 2760008, Hamburg, Germany

  • Investigational Site Number : 2760009, Landsberg, Germany

  • Investigational Site Number : 2760002, Münster, Germany

  • Investigational Site Number : 2760001, Tübingen, Germany

  • Investigational Site Number : 2760005, Wiesbaden, Germany

  • Investigational Site Number : 2760003, Würzburg, Germany

  • Investigational Site Number : 3480002, Budapest, Hungary

  • Investigational Site Number : 3480004, Debrecen, Hungary

  • Investigational Site Number : 3480003, Nyíregyháza, Hungary

  • Investigational Site Number : 3480001, Pécs, Hungary

  • Investigational Site Number : 3760007, Haifa, Israel

  • Investigational Site Number : 3760004, Kefar Sava, Israel

  • Investigational Site Number : 3760005, Petah Tikva, Israel

  • Investigational Site Number : 3760009, Tel Aviv, Israel

  • Azienda Ospedaliero-Universitaria di Ferrara-Site Number: 3800004, Cona, Ferrara, Italy

  • Azienda Ospedaliera Universitaria Careggi-Site Number : 3800011, Florence, Firenze, Italy

  • IRCCS Ospedale Policlinico San Martino-Site Number : 3800013, Genoa, Genova, Italy

  • ASST Santi Paolo e Carlo-Presidio Ospedale San Paolo-Site Number : 3800006, Milan, Milano, Italy

  • Azienda Ospedale - Università Padova-Site Number : 3800008, Padua, Padova, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Site Number: 3800002, Rome, Roma, Italy

  • Ospedale Bellaria-Site Number: 3800009, Bologna, Italy

  • Investigational Site Number : 3920010, Ichikawa, Chiba, Japan

  • Investigational Site Number : 3920004, Narita, Chiba, Japan

  • Investigational Site Number : 3920009, Isehara, Kanagawa, Japan

  • Investigational Site Number : 3920002, Odawara, Kanagawa, Japan

  • Investigational Site Number : 3920014, Yokohama, Kanagawa, Japan

  • Investigational Site Number : 3920005, Suwa, Nagano, Japan

  • Investigational Site Number : 3920012, Kusatsu, Shiga, Japan

  • Investigational Site Number : 3920006, Fukui, Japan

  • Investigational Site Number : 3920001, Fukuoka, Japan

  • Investigational Site Number : 3920011, Hiroshima, Japan

  • Investigational Site Number : 3920003, Kumamoto, Japan

  • Investigational Site Number : 3920013, Niigata, Japan

  • Investigational Site Number : 3920008, Tokyo, Japan

  • Investigational Site Number : 4840004, Chihuahua City, Mexico

  • Investigational Site Number : 4840003, Durango, Mexico

  • Investigational Site Number : 5280004, Alkmaar, Netherlands

  • Investigational Site Number : 5280002, Leiderdorp, Netherlands

  • Investigational Site Number : 6160006, Krakow, Lesser Poland Voivodeship, Poland

  • Investigational Site Number : 6160001, Wroclaw, Lower Silesian Voivodeship, Poland

  • Investigational Site Number : 6160004, Wroclaw, Lower Silesian Voivodeship, Poland

  • Investigational Site Number : 6160005, Lublin, Lublin Voivodeship, Poland

  • Investigational Site Number : 6160002, Warsaw, Masovian Voivodeship, Poland

  • Investigational Site Number : 6160003, Bialystok, Podlaskie Voivodeship, Poland

  • Investigational Site Number : 6200003, Guimarães, Portugal

  • Investigational Site Number : 6200004, Matosinhos Municipality, Portugal

  • Investigational Site Number : 6200002, Porto, Portugal

  • Investigational Site Number : 6200001, Santa Maria da Feira, Portugal

  • Investigational Site Number : 4100005, Cheonan-Si, Chungcheongnam-do, South Korea

  • Investigational Site Number : 4100009, Seongnam-si, Gyeonggi-do, South Korea

  • Investigational Site Number : 4100008, Incheon, Incheon-gwangyeoksi, South Korea

  • Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100004, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100006, Seoul, South Korea

  • Investigational Site Number : 7240007, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240003, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240008, Barcelona, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240002, Barcelona, Catalunya [Cataluña], Spain

  • Investigational Site Number : 7240004, Jerez de la Frontera, Cádiz, Spain

  • Investigational Site Number : 7240001, Majadahonda, Madrid, Spain

  • Investigational Site Number : 7240006, Seville, Sevilla, Spain

  • Investigational Site Number : 7240009, Sabadell, Spain

  • Investigational Site Number : 7240005, Zaragoza, Spain

  • Investigational Site Number : 7520002, Lund, Sweden

  • Investigational Site Number : 7520001, Solna, Sweden

  • Investigational Site Number : 7520004, Stockholm, Sweden

  • Investigational Site Number : 7920003, Ankara, Turkey (Türkiye)

  • Investigational Site Number : 7920001, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 7920002, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 8260002, London, London, City of, United Kingdom

  • Investigational Site Number : 8260006, Oxford, Oxfordshire, United Kingdom

  • Investigational Site Number : 8260004, Bradford, United Kingdom

  • Investigational Site Number : 8260001, Newcastle upon Tyne, United Kingdom

Study leads
  • Clinical Sciences & Operations

    Study Director

    Sanofi